AcquireWire
EasyJet Backs Apollo's £5.7bn Takeover Bid, Shares Jump 14%
The budget carrier has agreed in principle to a $7.7bn offer from Apollo, snubbing rival Castlelake and sending shares to their sharpest single-day gain in years.
Hugo Boss Board Rebuffs Frasers' $2.2 Billion Takeover Bid
The German fashion house is urging shareholders to reject Mike Ashley's Frasers Group, calling the £2.2 billion approach inadequate — setting up a contested public battle over one of Europe's most recognisable luxury-adjacent brands.
Yara Pays $1.3 Billion for Gulf Coast Ammonia Plant in Bet on U.S. Fertilizer Supply
The Norwegian fertilizer giant is committing $1.3 billion to secure a U.S. ammonia foothold — a strategic pivot toward domestic supply chains at a moment of acute fertilizer-market volatility.
Castlelake Bids $6.7–7.3B for easyJet in Rare Budget-Airline Take-Private
The U.S. private equity firm has tabled a takeover offer for the London-listed low-cost carrier, with reported figures ranging from $6.7 billion to $7.3 billion. EasyJet says it is ready to accept — setting up one of the largest PE plays in European aviation in years.
Comcast's Sky Buys ITV for $2.16 Billion, Redrawing British Broadcasting
Sky has made the ITV acquisition official at $2.16 billion, combining the UK's dominant pay-TV platform with its largest commercial free-to-air broadcaster — a consolidation that hands Comcast a vertically integrated content and distribution giant.
Ecolab Pays $4.75bn for CoolIT to Bet on AI's Heat Problem
The water-and-hygiene giant closes its largest-ever deal to capture liquid-cooling demand from hyperscalers, targeting $4 billion in high-tech revenue by 2030.
Kroger Strikes $1.65B Deal for Giant Eagle, Doubling Down on Regional Grocery Scale
Less than a year after its blocked Albertsons merger, Kroger is back on the acquisition trail with a $1.65 billion bid for Giant Eagle — a move that tests antitrust tolerance and reshapes the competitive map across the Mid-Atlantic and Midwest.
Perpetual Rebuffs EQT's $1.7B Takeover, But the Door Isn't Closed
The Australian wealth manager has rejected a $1.7 billion approach from Swedish PE giant EQT, setting up a standoff over valuation in a sector already under consolidation pressure.
Zymeworks Bets $929M on Theravance to Break Out of Oncology
The Canadian biotech is paying $929 million to absorb Theravance Biopharma, a move that doubles its therapeutic footprint but loads the balance sheet just as its own cancer pipeline matures.
Danaher Closes $9.9B Masimo Deal, Betting Big on Patient Monitoring
The diagnostics conglomerate has completed its largest acquisition in recent years, absorbing Masimo's hospital-grade monitoring business for $9.9 billion — a bet that healthcare infrastructure spending holds even as budgets tighten.
AES Shareholders Green-Light Takeover by GIP-EQT Consortium
Stockholders have voted to approve the sale of AES Corporation to a consortium led by Global Infrastructure Partners and EQT, clearing a critical milestone for one of the larger infrastructure take-privates in recent memory.
Merck Agrees to Buy Bio-Techne for $11.3 Billion
The deal sends Bio-Techne shares surging roughly 20%, handing Merck a deep portfolio of life-science reagents and diagnostics tools at a substantial premium.
EasyJet Rebuffs Castlelake But Leaves the Runway Clear
The budget carrier has rejected the private-credit firm's latest takeover approach while pointedly refusing to slam the door — a posture that signals price, not principle, is the sticking point.
Prologis Lobbed a £12.6bn Bid at Segro. Segro Said No.
The US logistics-property giant made an unsolicited approach for its UK rival at £12.6 billion — Segro's board rejected it as undervaluing the company, sending shares sharply higher.
AbbVie Bets $10.9B on Apogee's Next-Gen Eczema Drug
The pharma giant is paying a substantial premium for Apogee Therapeutics and its lead immunology asset, doubling down on a category it already dominates — but where Dupixent competition is intensifying.
CRH Pays $8.5 Billion for Arcosa, Doubling Down on U.S. Infrastructure Materials
The Irish building-materials giant is making its largest U.S. bet yet, snapping up Arcosa's aggregates and infrastructure products business at a moment when American infrastructure spending is near peak cycle. The deal also implies a meaningful premium for Arcosa shareholders, whose stock jumped on the news.
PPHE Hotel Group Craters 17% as Fattal Walks Away
The collapse of Fattal's takeover approach wiped roughly a fifth of PPHE's market value in a single session, a brutal reminder of how much bid premium hospitality stocks are carrying right now.
Paramount-Skydance Deal Clears China and U.S. States Move to Block It
Chinese regulators have signed off on the Paramount Skydance–Warner Bros. Discovery combination, even as U.S. state attorneys general prepare a legal challenge that could complicate the final stretch.
SpaceX Pays $60 Billion in Stock for Cursor, Minting New Fortunes Overnight
Elon Musk's private rocket company has agreed to acquire AI coding tool Cursor in a deal valued at $60 billion — one of the largest all-stock acquisitions by a private company in history — doubling the net worths of its twenty-something co-founders in a single transaction.
Fox Bets $22B on Roku to Rewrite Its Streaming Future
Fox Corporation is acquiring Roku for $22 billion, a deal that would give the traditional broadcaster direct ownership of the dominant U.S. streaming platform—and put Wall Street in a skeptical mood.
Frasers Group Tables £2.3 Billion Takeover Bid for Hugo Boss
Mike Ashley's retail vehicle has launched a formal offer for the German luxury house, putting one of Europe's most-watched activist holdings into play. The bid crystallises years of stake-building—and a bruising governance battle.
Amwins and Dragoneer Table A$7.7 Billion Offer for Steadfast
A consortium of U.S. specialty insurer Amwins and growth investor Dragoneer has lobbed a A$7.7 billion acquisition offer at ASX-listed insurance broker Steadfast, setting up a potential take-private of one of Australasia's largest broking networks.
GSK Bets Big on Nuvalent in Latest Oncology Push
GSK has agreed to acquire clinical-stage cancer drug maker Nuvalent, adding a pipeline of next-generation kinase inhibitors as the pharma giant races to replenish its oncology portfolio.
Intesa Sanpaolo Launches €30.6 Billion Bid for Monte dei Paschi, Reshaping Italian Banking
Italy's largest bank has tabled a takeover offer for MPS worth roughly €30.6 billion, muscling into a three-way contest that could redraw the country's entire financial map.
State AGs Move to Kill the Paramount-Warner Bros. Deal
Multiple US states are preparing a lawsuit to block Paramount's acquisition of Warner Bros. Discovery, sending both stocks sharply lower and injecting fresh legal risk into one of media's most consequential consolidations.
Somnigroup's $2.5B Leggett Deal Gets Antitrust Green Light
The bedding giant's acquisition of Leggett & Platt's relevant business has cleared U.S. antitrust review, removing the biggest regulatory hurdle to a deal that reshapes the sleep-products supply chain.
Universal Music Spurns Ackman's $65 Billion Bid
UMG has rejected a takeover approach from Bill Ackman's Pershing Square valued at $65 billion, setting up a standoff between the world's largest music company and one of Wall Street's most prominent activist investors.
Howard Hughes Closes $2.1bn Vantage Deal, Pivoting Hard Into Reinsurance
The master-planned community developer has completed its acquisition of Vantage Group Holdings for $2.1 billion, a sharp strategic turn toward insurance capital that redefines what Howard Hughes actually is.
Bally's-Intralot Consortium Bags Evoke for $326 Million
The UK-listed online gambling operator's board has accepted a takeover offer from a joint venture of Bally's and Greek lottery giant Intralot, handing shareholders a lifeline after a period of operational turbulence.
REPAY Closes $372M KUBRA Deal to Dominate Consumer Bill Payment
The fintech closes its largest-ever acquisition, betting that owning a major utility and insurance billing platform supercharges its payment volume and cross-sell runway.
NextEra-Dominion: The Utility Mega-Merger Reshaping Nuclear Power in New England
A potential combination of two of America's largest utilities could redraw the clean-energy map for the Northeast — with nuclear capacity at the center of the debate.
S&P, Nasdaq, and Dow All Closed at Records. The Market Has Stopped Caring About Iran.
The S&P sits at 7,529. Three indexes at all-time highs simultaneously. Oil fell again on reports Iran will restore pre-war Hormuz traffic within a month. The market is pricing in resolution. The Pentagon is still bombing.
Nvidia Just Did $81.6B in a Quarter and Said It Will Spend $150B in Taiwan a Year
Record Q1 revenue up 85%. Data center revenue up 92%. An additional $80B buyback authorization. And a 10x increase in Taiwan spending. Huang called the AI buildout "the largest infrastructure expansion in human history." The numbers back him up.
SK Hynix and Micron Both Hit $1 Trillion. Memory Just Joined the AI Trade.
Two memory chip makers crossed the trillion-dollar threshold on the same day, sending the S&P to a new record. HBM is suddenly the most valuable commodity in semiconductors. Two years ago, this industry was in a glut.
The U.S. and Iran Have a "Framework." The U.S. Is Also Still Bombing.
A 60-day ceasefire extension. The Strait of Hormuz to be de-mined and reopened. $24B in frozen Iranian assets potentially unlocked. And U.S. "self-defense" strikes hitting Iranian missile sites the same week the framework was announced. The market is buying peace; the Pentagon is hedging.
Mastercard Pays Up to $1.8B for BVNK to Buy Its Way Into Stablecoins
The payments giant is acquiring a London-based stablecoin infrastructure company that has gone from $12B to $30B in annualized volume in nine months. Mastercard is no longer trying to slow crypto. It is trying to own the rails.
SpaceX Filed for a $1.75 Trillion IPO. It Would Be the Largest in History by Six Times.
June 12 listing on Nasdaq under SPCX. A $75 billion raise. A combined entity covering rockets, Starlink, and xAI. And a $4.94B net loss in 2025 to go with it. The largest IPO ever attempted is also the most contested valuation on Wall Street.
KKR Just Bought the Largest Investor in Sports Team Stakes for $1.95B
Arctos Partners manages $16B in AUM across NBA, MLB, NHL, and F1 team investments. KKR is paying $1.4B upfront plus $550M in performance equity. Sports franchise ownership is no longer a billionaire hobby. It is an institutional asset class.
An AI-Focused PE Firm Just Took Amex GBT Private at a 60% Premium
Long Lake Management, founded in 2023 to buy services businesses and "modernize them with AI," is paying $6.3B for the world's largest corporate travel platform. American Express, Expedia, Qatar Investment Authority, and BlackRock all rolled.
Allbirds Sold Its Shoes for $39M and Became an AI Company. The Stock Rose 582%.
The $4 billion sustainable sneaker darling of 2021 is now "NewBird AI," a GPU-as-a-Service provider. It is dropping its B Corp environmental commitments. It has $50 million in financing. The Long Island Iced Tea comparisons write themselves.
The S&P 500 Hit an All-Time High. It Took 10 Trading Days to Erase a War.
7,022.95. A new record, surpassing the January peak. The Nasdaq posted its longest winning streak in history. The index rose 9.8% in 10 sessions, faster than the COVID rebound. Whether the optimism is justified is another question entirely.
Goldman and JPMorgan Posted Record Numbers. Their Stocks Fell Anyway.
Goldman hit its highest-ever equities trading quarter and JPMorgan earned $5.94 per share. Both beat estimates handily. Both stocks dropped on the day. The market is telling you it cares more about Iran than about earnings.
Amazon Pays $11.6B for Globalstar and an Apple Partnership to Take On Starlink
The deal hands Amazon Leo a functioning satellite fleet, Apple as a locked-in customer, and the globally licensed Band 53 spectrum that SpaceX reportedly wanted. AMZN rose 5%, GSAT jumped 10%.
Gas Prices Just Posted Their Biggest Monthly Jump Since 1967. The Fed Noticed.
March CPI came in at 0.9% monthly and 3.3% annual, driven almost entirely by a 21.2% spike in gasoline. But core inflation was cooler than expected, and the real question is what happens when the war premium fades and the Fed still can't cut.
Carlyle's $7B Private Credit Fund Just Gated Investors. It Won't Be the Last.
Redemption requests hit 15.7% of shares, three times the 5% limit. Carlyle paid out less than a third of what investors asked for. Morgan Stanley, BlackRock, and Apollo have all capped withdrawals in recent weeks.
Meta Commits $21B More to CoreWeave, Bringing Total AI Cloud Spend to $35B
The expanded deal runs through 2032, locks in early access to Nvidia's Vera Rubin chips, and makes Meta roughly 40% of CoreWeave's projected capacity for the rest of the decade.
The Ceasefire Rally: Seven Straight Days, Oil Below $100, and the Dow Back in the Green
The S&P 500's longest winning streak since October. WTI crude's biggest single-day plunge since April 2020. Semis leading, energy lagging, and the Fed worried about inflation. A market snapshot from a week that moved everything.
Anthropic Hit $30B in Revenue Run Rate and Overtook OpenAI in Four Months
From $9B to $30B since December. 1,000+ enterprise clients at $1M+. A 3.5 gigawatt compute deal with Google and Broadcom. And a Pentagon dispute that hasn't slowed it down.
Neurocrine Pays $2.9B for a Drug That Sells Itself at $466K a Year
The neuroscience company is buying Soleno Therapeutics at a 34% premium to lock up Vykat XR, the only approved treatment for the insatiable hunger of Prader-Willi syndrome, with just 12.5% of patients reached so far.
Goldman Sachs Pays $2B for the Firm That Invented the Buffer ETF
The acquisition of Innovator Capital Management vaults Goldman to 240 ETFs and $90B in ETF assets, buying its way into the fastest-growing corner of asset management at 7.1% of AUM.
McCormick and Unilever Are Merging Their Way to a $65B Flavor Empire
The second-largest food deal in history pairs Hellmann's and Knorr with McCormick's spice rack in a $44.8B Reverse Morris Trust. Investors punished both stocks anyway.